Rafferty Asset Management’s Constellation Pharmaceuticals, Inc. CNST Stock Holding History

Rafferty Asset Management’s Portfolio CNST Stock Details CNST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-55,592	Closed	-$1.88M	–	1334
2021 Q2	$1.88M	Sell	55,592 -55,362	-50%	-$1.41M	0.01%	704
2021 Q1	$2.6M	Buy	110,954 +94,648	+580%	+$2.87M	0.02%	557
2020 Q4	$470K	Sell	16,306 -48,742	-75%	-$1.23M	﹤0.01%	697
2020 Q3	$1.32M	Buy	65,048 +49,415	+316%	+$1.21M	0.02%	532
2020 Q2	$470K	Buy	+15,633	New	+$563K	0.01%	730

Rafferty Asset Management's CNST Position: Q3 2021 in Review

Rafferty Asset Management sold out of Constellation Pharmaceuticals, Inc. (CNST) in Q3 2021, closing a stake of 55,592 shares — an estimated $1.88M sold.

Rafferty Asset Management first reported a position in CNST in Q2 2020 and held it in 5 quarters. The position peaked at $2.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold CNST as of Q3 2021.

Rafferty Asset Management reported no remaining Constellation Pharmaceuticals, Inc. position as of Q3 2021 after selling out during the quarter.
Rafferty Asset Management sold 55,592 Constellation Pharmaceuticals, Inc. shares in Q3 2021, an estimated $1.88M.
Rafferty Asset Management first reported a position in Constellation Pharmaceuticals, Inc. in Q2 2020 and held it in 5 quarters.
Rafferty Asset Management's Constellation Pharmaceuticals, Inc. position peaked at $2.6M in Q1 2021.
0 funds tracked by Wall St. Rank held Constellation Pharmaceuticals, Inc. as of Q3 2021.

Based on Rafferty Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.